Cardiovascular
PulseCath lands CE mark for mechanical circulatory support device
Netherlands-based PulseCath has received a CE mark under the EU Medical Device Regulation (MDR) for its mechanical circulatory support device,…
Aria CV implants first patient with pulmonary hypertension system
Aria CV has kicked off its ASPIRE PH trial and successfully implanted the first patient with its system to treat…
China’s Zylox-Tonbridge looks to expand into the Gulf region
Chinese MedTech company Zylox-Tonbridge has received marketing approvals for five of its devices from the UAE’s Ministry of Health and…
BiVACOR secures $13m for total artificial heart programme
US-based BiVACOR has been awarded $13m from the Australian Government’s Medical Research Future Fund (MRFF) to advance its total artificial…
Endovascular Engineering treats first patient in trial of Hēlo system
Endovascular Engineering (E2) has treated the first subject in the pivotal phase of its ENGULF US clinical trial of the…
Cagent secures funding to expand portfolio of angioplasty technology
Cagent Vascular has closed a series C financing round, raising more than $30m, to expedite US market adoption and expand…
FDA AdCom votes in favour of Abbott’s tricuspid valve repair system
A US Food and Drug Administration (FDA) advisory committee (AdCom) has recommended approval of Abbott’s TriClip transcatheter edge-to-edge repair (TEER)…
Roche launches Factor Xa inhibitor coagulation tests in Europe
Roche has launched three coagulation tests for three oral Factor Xa inhibitors namely apixaban, edoxaban and rivaroxaban, in European countries…
J&J’s Varipulse system achieves freedom for atrial arrhythmia recurrence
Biosense Webster, part of Johnson & Johnson MedTech, has reported 12-month results from the inspIRE and admIRE trials demonstrating month…
FEops study shows HEARTguide boosts LAAO procedure efficiency
FEops has reported that data from a US-based comprehensive single centre experience where left atrial appendage occlusion (LAAO) procedures planned…